Srećković B and colleagues showed that patients with MS had statistically significant higher values ​​of abdominal obesity, hypertriglyceridemia, hypertension, IR, CRP, microalbuminuria and homocysteine, which promote endothelial dysfunction and accelerated development of vascular complications. Here, CRP is linked to myeloid sarcoma.